valerates has been researched along with aspirin in 4 studies
| Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 2,251 | 294 | 457 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | valerates (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnout, J; De Reys, S; Deckmyn, H; Falcon, C; Hoet, B; Vermylen, J | 1 |
| Arnout, J; Hoet, B; Vermylen, J | 1 |
| Azarnoff, DL; Svoboda, DJ | 1 |
| Doroszko, A; Jurasz, P; Moncada de la Rosa, C; Radziwon-Balicka, A; Zielnik, B | 1 |
2 trial(s) available for valerates and aspirin
| Article | Year |
|---|---|
R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
Topics: Aspirin; Bleeding Time; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Pentanoic Acids; Phosphoproteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase; Valerates | 1990 |
R68070, a combined thromboxane/endoperoxide receptor antagonist (TRA) and thromboxane synthase inhibitor (TSI), prolongs the bleeding time more than aspirin in man.
Topics: Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Humans; In Vitro Techniques; Male; Pentanoic Acids; Prostaglandins; Pyridines; Random Allocation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase; Valerates | 1989 |
2 other study(ies) available for valerates and aspirin
| Article | Year |
|---|---|
Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Anticholesteremic Agents; Aspirin; Blood Proteins; Catalase; Clofibrate; D-Amino-Acid Oxidase; Hypolipidemic Agents; Lipids; Liver; Male; Mitochondria, Liver; Organoids; Oxidoreductases; Propionates; Protein Binding; Rats; Thyroxine; Valerates | 1969 |
Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration.
Topics: Adenine; Angiogenesis Inhibitors; Angiostatins; Aspirin; Blood Platelets; Cell Hypoxia; Cell Line; Cell Movement; Collagen; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Humans; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; S-Nitrosoglutathione; Valerates; Vascular Endothelial Growth Factor A | 2013 |